Current Report Filing (8-k)
July 06 2017 - 4:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): June 29, 2017
CEL-SCI CORPORATION
(Exact name of Registrant as specified in its charter)
Colorado 001-11889 84-0916344
---------------------------- --------------------- ------------------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
|
8229 Boone Boulevard, Suite 802
Vienna, Virginia 22182
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (703) 506-9460
N/A
(Former name or former address if changed since last report)
Item 3.03. Material Modification to Rights of Security Holders.
On June 29, 2017 the Company extended the expiration date of its Series DD
warrants by one month from July 10, 2017 to August 10, 2017. The Series DD
warrants were issued as part of a financing on December 8, 2016. As a result of
the reverse stock split approved by the Company's shareholders and adopted by
the Company's directors, the holders of the Series DD warrants are entitled to
purchase 1,360,960 shares of the Company's common stock at an exercise price of
$4.50 per share
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 5, 2017 CEL-SCI CORPORATION
By: /s/ Patricia Prichep
-------------------------------
Patricia Prichep
Senior Vice President of Operations
|
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Sep 2023 to Sep 2024
